Medicine and Dentistry
Activated Protein C
17%
Activated Protein C Resistance
24%
Analysis
9%
Antibody
39%
Antigen
24%
Antithrombotic
8%
APC
6%
Arm
12%
Assay
59%
Authority
8%
Biological Marker
27%
Bleeding
27%
Blood
8%
Blood Clotting Factor 10a Inhibitor
6%
Blood Stasis
48%
Bone Turnover
24%
Booster Dose
9%
Carbohydrate Metabolism
16%
Cells
48%
Cellular Immunity
24%
Coagulopathy
24%
Consensus
24%
Corticosteroid
6%
COVID-19
80%
Cytokine Response
24%
Deep Vein Thrombosis
6%
Dextran Sulfate
24%
Diagnosis
24%
Diagnostic Error
6%
Diagnostic Test
8%
Direct Oral Anticoagulant
24%
Direct Thrombin Inhibitor
6%
Disease
9%
Drospirenone
24%
Drug Dose Regimen
7%
Estetrol
48%
Extracellular Trap
12%
Gamma Interferon
8%
Genetic Transfection
8%
Gestagen
6%
Hemostat
5%
Histone
18%
Host Cell
8%
Human
24%
Human Cell
8%
Humoral Immunity
35%
Immune Response
15%
Immunogenicity
24%
In Vitro
8%
Infection
29%
Influenza
8%
Inpatient
24%
Laboratory
33%
Laboratory Assessment
6%
Laboratory Medicine
24%
Leukocyte Elastase
6%
Levonorgestrel
9%
Lipid
13%
Liver Function
6%
Low Drug Dose
6%
Lung
24%
Measurement
16%
Messenger RNA
24%
Metabolism
24%
mRNA Vaccine
6%
Neutralizing Antibody
100%
Neutrophil
18%
Nucleosome
24%
Observational Study
24%
Oral Contraceptive Agent
9%
Pathogen
8%
Patient
63%
Placebo
24%
Plaque
8%
Post-Analytical Phase
6%
Postmenopause
24%
Procoagulant
5%
Protein
20%
Quantitative Reverse Transcription Polymerase Chain Reaction
8%
Receptor
8%
Receptor Binding
8%
Reproducibility
6%
Satisfaction
12%
Screening
6%
Septic Shock
24%
Serositis
9%
Serum
20%
Severe Acute Respiratory Syndrome Coronavirus 2
78%
Sex Hormone Binding Globulin
6%
Stimulation
8%
Syndrome
24%
T Cell
8%
Therapeutic Procedure
6%
Thrombin
48%
Thrombocyte Activation
6%
Thrombocytopenia
24%
Thrombosis
24%
Transplantation
24%
Vaccine
54%
Virus
36%
Virus Infection
8%
Virus Neutralization
24%
Wassermann Test
17%
Woman
34%
Immunology and Microbiology
Adoptive Immunity
24%
Antibody Titer
7%
Antigen
48%
Antigen Response
6%
Binding Antibody
51%
Booster Dose
9%
Breakthrough Infection
24%
Cells
24%
Clotting Time
14%
COVID-19
24%
Cycle Threshold
6%
Cytolysis
8%
Dose
12%
Host Cell
8%
Human Cell
8%
Humoral Immunity
27%
Immune Response
6%
Immunogenicity
24%
Infectious Agent
8%
Influenza
24%
Interferon Gamma
8%
Kinetics
6%
Laboratory Test
24%
Lung Transplantation
24%
Monospecific Antibody
11%
Neutralizing Antibody
75%
Omicron Coronavirus Variant
24%
Plaque Reduction Neutralization Test
8%
Platelet Factor 4
12%
Receptor Binding
8%
Respiratory Syncytial Virus
24%
Reverse Transcription Polymerase Chain Reaction
12%
Sample
10%
Sampling
6%
Screening Test
9%
Severe Acute Respiratory Syndrome Coronavirus 2
48%
Spike
19%
Surface Property
8%
T Cell
8%
Thrombin
19%
Time
8%
Titer
9%
Vaccine Efficacy
36%
Viral Disease
8%
Viral Entry
8%
Viral Load
13%
Viremia
6%
Pharmacology, Toxicology and Pharmaceutical Science
Absence
6%
Activated Protein C Resistance
24%
Anticoagulant Agent
13%
Antigen
24%
Antivitamin K
11%
Atrial Fibrillation
24%
Blindness
24%
Blood Clotting Disorder
24%
Blood Clotting Factor 8
6%
Blood Clotting Inhibitor
9%
Clinical Study
5%
Clotting Time
37%
Coronavirinae
28%
Cytokine
24%
Dexamethasone
24%
Diethylstilbestrol
6%
Direct Oral Anticoagulant
79%
Disease Severity
9%
Diseases
28%
Drospirenone
24%
Edoxaban
26%
Emergency
24%
Endocrine Therapy
8%
Estetrol
48%
Estrogen
8%
Estrogen Receptor
12%
Ethinylestradiol
18%
F Factor
6%
Fibrinolytic Agent
6%
Genetic Disorder
6%
Hemostatic Agent
10%
Heparin
11%
Hormone
6%
Inflammation
12%
Levonorgestrel
9%
Nuclear Estrogen
6%
Placebo
16%
Protein S Deficiency
6%
Prothrombin
20%
RNA Directed DNA Polymerase
9%
SARS Coronavirus
28%
Symptom
9%
Thromboembolism
8%
Thromboplastin
10%
Tolerability
10%
Venous Thromboembolism
12%